{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T16:27:53Z","timestamp":1793809673104,"version":"4.6.1"},"reference-count":68,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"5_Suppl","license":[{"start":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T00:00:00Z","timestamp":1793664000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,11,3]]},"abstract":"<jats:title>ABSTRACT.<\/jats:title>\n                  <jats:p>\n                    South Africa is one of 25 countries identified by the WHO as having the potential to eliminate malaria in the near future. In response to the emerging threat of antimalarial resistance, South Africa has enhanced its surveillance programs to enable the mapping of the prevalence of resistance markers at the facility level. A total of 4,471 samples, collected between January 2022 and August 2024 from healthcare facilities and during active surveillance in malaria-eliminating districts in KwaZulu-Natal and Mpumalanga Provinces, were assessed for drug (mutations in the\n                    <jats:italic>kelch13<\/jats:italic>\n                    ,\n                    <jats:italic>chloroquine resistance transporter<\/jats:italic>\n                    [\n                    <jats:italic>crt<\/jats:italic>\n                    ],\n                    <jats:italic>multidrug resistance 1<\/jats:italic>\n                    [\n                    <jats:italic>mdr1<\/jats:italic>\n                    ],\n                    <jats:italic>dihydrofolate reductase<\/jats:italic>\n                    [\n                    <jats:italic>dhfr<\/jats:italic>\n                    ], and\n                    <jats:italic>dihydropterate synthase<\/jats:italic>\n                    [\n                    <jats:italic>dhps<\/jats:italic>\n                    ] genes) and diagnostic (\n                    <jats:italic>histidine-rich protein 2\/3<\/jats:italic>\n                    [\n                    <jats:italic>hrp2\/3<\/jats:italic>\n                    ] gene deletions) resistance markers using polymerase chain reaction testing and sequencing (Sanger or targeted amplicon) protocols. Validated markers of artemisinin partial resistance were rare, with the P574L mutation detected as a minor allele in two samples and the P553L mutation present in one sample. Of the 60 additional nonsynonymous mutations detected, the A578S (30\/999) and the I494V (13\/951) mutations were most prevalent. Almost all parasites assessed carried the\n                    <jats:italic>crtK76<\/jats:italic>\n                    (99.8%) and\n                    <jats:italic>mdr1N<\/jats:italic>\n                    86 (99.0%) alleles, suggesting susceptibility to chloroquine. The\n                    <jats:italic>dhfr<\/jats:italic>\n                    triple (99.9%) and\n                    <jats:italic>dhps<\/jats:italic>\n                    double (98.2%) mutations associated with pyrimethamine and sulfadoxine resistance, respectively, were close to fixation. No single or double\n                    <jats:italic>hrp2\/3<\/jats:italic>\n                    gene deletions were detected. These findings suggest that the recommended treatments and diagnostics in South Africa are effective. However, the strong selection for antimalarial drug resistance markers across southern Africa, combined with high regional interconnectedness, emphasizes the need for sustained malaria molecular surveillance to support South Africa and the southern Africa region in achieving their elimination goals.\n                  <\/jats:p>","DOI":"10.4269\/ajtmh.25-0204","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T15:52:28Z","timestamp":1761234748000},"page":"53-64","source":"Crossref","is-referenced-by-count":5,"title":["Very Low Prevalence of Validated kelch13 Mutations and Absence of Histidine-Rich Protein 2\/3 Double Gene Deletions in South African Malaria-Eliminating Districts (2022\u20132024)"],"prefix":"10.4269","volume":"115","author":[{"given":"Jaishree","family":"Raman","sequence":"first","affiliation":[{"name":"Centre for Emerging Zoonotic and Parasitic Diseases, National Institute for Communicable Diseases, Johannesburg, South Africa;"},{"name":"Wits Research Institute for Malaria, University of Witwatersrand, Johannesburg, South Africa;"},{"name":"Institute for Sustainable Malaria Control, University of Pretoria, Pretoria, South Africa;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxwell","family":"Mabona","sequence":"additional","affiliation":[{"name":"Centre for Emerging Zoonotic and Parasitic Diseases, National Institute for Communicable Diseases, Johannesburg, South Africa;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qedusizi","family":"Nyawo","sequence":"additional","affiliation":[{"name":"KwaZulu-Natal Provincial Malaria Control Program, Jozini, South Africa;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brighton","family":"Mangena","sequence":"additional","affiliation":[{"name":"Elimination Eight, Windhoek, Namibia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerdalize","family":"Kok","sequence":"additional","affiliation":[{"name":"Mpumalanga Provincial Malaria Control Program, Mbombela, South Africa;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihle","family":"Mathaba","sequence":"additional","affiliation":[{"name":"Mpumalanga Provincial Malaria Control Program, Mbombela, South Africa;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Malatje","sequence":"additional","affiliation":[{"name":"Mpumalanga Provincial Malaria Control Program, Mbombela, South Africa;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja B.","family":"Lauterbach","sequence":"additional","affiliation":[{"name":"Centre for Emerging Zoonotic and Parasitic Diseases, National Institute for Communicable Diseases, Johannesburg, South Africa;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takalani I.","family":"Makhanthisa","sequence":"additional","affiliation":[{"name":"Centre for Emerging Zoonotic and Parasitic Diseases, National Institute for Communicable Diseases, Johannesburg, South Africa;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazel","family":"Gwarinda","sequence":"additional","affiliation":[{"name":"Centre for Emerging Zoonotic and Parasitic Diseases, National Institute for Communicable Diseases, Johannesburg, South Africa;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bla\u017eenka D.","family":"Letini\u0107","sequence":"additional","affiliation":[{"name":"Centre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, South Africa;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arinao","family":"Ndadza","sequence":"additional","affiliation":[{"name":"Centre for Emerging Zoonotic and Parasitic Diseases, National Institute for Communicable Diseases, Johannesburg, South Africa;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Raswiswi","sequence":"additional","affiliation":[{"name":"KwaZulu-Natal Provincial Malaria Control Program, Jozini, South Africa;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mbavhalelo","family":"Shandukani","sequence":"additional","affiliation":[{"name":"National Department of Health, Pretoria, South Africa;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ednah","family":"Baloyi","sequence":"additional","affiliation":[{"name":"National Department of Health, Pretoria, South Africa;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyanda","family":"Fekema","sequence":"additional","affiliation":[{"name":"National Department of Health, Pretoria, South Africa;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arshad","family":"Ismail","sequence":"additional","affiliation":[{"name":"Sequencing Core Facility, National Institute for Communicable Diseases, Johannesburg, South Africa;"},{"name":"Department of Biochemistry and Microbiology, Faculty of Science, Engineering and Agriculture, University of Venda, Thohoyandou, South Africa;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Featherston","sequence":"additional","affiliation":[{"name":"Sequencing Core Facility, National Institute for Communicable Diseases, Johannesburg, South Africa;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Greenhouse","sequence":"additional","affiliation":[{"name":"EPPIcenter Research Program, Department of Medicine, University of California San Francisco, San Francisco, California, USA;"},{"name":"Malaria Elimination Initiative, University of California San Francisco, San Francisco, California, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Smith","sequence":"additional","affiliation":[{"name":"Malaria Elimination Initiative, University of California San Francisco, San Francisco, California, USA;"},{"name":"Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Aranda-Diaz","sequence":"additional","affiliation":[{"name":"EPPIcenter Research Program, Department of Medicine, University of California San Francisco, San Francisco, California, USA;"},{"name":"Malaria Elimination Initiative, University of California San Francisco, San Francisco, California, USA;"},{"name":"ISGlobal, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2795","reference":[{"key":"b1","article-title":"World Malaria Day: WHO Launched an Effort to Stamp Malaria in 25 More Countries by 2025.","year":"2021"},{"key":"b2","article-title":"Global Risk of Selection and Spread of Plasmodium falciparum Histidine-Rich-Protein 2 and 3 Gene Deletions.","author":"Watson","year":"2023"},{"key":"b3","series-title":"Int J Parasitol Drugs Drug Resist","first-page":"155","article-title":"A review of the frequencies of Plasmodium falciparum Kelch13 artemisinin resistance mutations in Africa","volume":"16","author":"Ndwiga","year":"2021"},{"key":"b4","series-title":"Am J Trop Med Hyg","first-page":"181","article-title":"Artemisinin-based combination treatment of falciparum malaria","volume":"77","author":"Nosten","year":"2007"},{"key":"b5","series-title":"J Parasitol Res","first-page":"7371681","article-title":"Therapeutic efficacy of artemether-lumefantrine (Coartem) for the treatment of uncomplicated falciparum malaria in Africa: A systematic review","volume":"2020","author":"Derbie","year":"2020"},{"key":"b6","article-title":"Strategy to Respond to Antimalarial Drug Resistance in Africa.","year":"2022"},{"issue":"9","key":"b7","series-title":"Lancet Infect Dis","first-page":"e591","article-title":"The emergence of artemisinin partial resistance in Africa: How do we respond?","volume":"24","author":"Rosenthal","year":"2024"},{"issue":"5","key":"b8","series-title":"Curr Opin Infect Dis","first-page":"432","article-title":"Artemisinin and multidrug-resistant Plasmodium falciparum \u2013 A threat for malaria control and elimination","volume":"34","author":"Dhorda","year":"2021"},{"issue":"13","key":"b9","series-title":"N Engl J Med","first-page":"1191","article-title":"Increasing prevalence of artemisinin-resistance HRP2-negative malaria in Eritrea","volume":"389","author":"Mihreteab","year":"2023"},{"key":"b10","series-title":"Malar J","first-page":"283","article-title":"Plasmodium falciparum parasites lacking histidine-rich protein 2 and 3: A review and recommendations for accurate reporting","volume":"13","author":"Cheng","year":"2014"},{"key":"b11","article-title":"Statement by the Malaria Policy Advisory Group on the Urgent Need to Address the High Prevalence of pfhrp2\/3 Gene Deletions in the Horn of Africa and Beyond.","year":"2021"},{"issue":"1","key":"b12","series-title":"Malar J","first-page":"280","article-title":"Absence of kelch13 artemisinin resistance markers but strong selection for lumefantrine-tolerance molecular markers following 18 years of artemisinin-based combination therapy use in Mpumalanga, South Africa (2001\u20132018)","volume":"18","author":"Raman","year":"2019"},{"key":"b13","series-title":"Malar J","first-page":"438","article-title":"Reviewing South Africa\u2019s malaria elimination strategy (2012-2018): Progress, challenges and priorities","volume":"15","author":"Raman","year":"2016"},{"key":"b14","series-title":"PLoS Med","first-page":"e330","article-title":"Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal","volume":"2","author":"Barnes","year":"2005"},{"key":"b15","series-title":"Malar J","first-page":"207","article-title":"Making data map-worthy-enhancing routine malaria data to support surveillance and mapping of Plasmodium falciparum anti-malarial resistance in a pre-elimination sub-Saharan African setting: A molecular and spatiotemporal epidemiology study","volume":"21","author":"Kagoro","year":"2022"},{"key":"b16","series-title":"S Afr Med J","first-page":"861","article-title":"Re-defining the extent of malaria transmission in South Africa: Implications for chemoprophylaxis","volume":"103","author":"Morris","year":"2013"},{"key":"b17","article-title":"Guidelines for the Treatment of Malaria, 2019.","year":"2019"},{"issue":"10 Pt 2","key":"b18","series-title":"SAMJ","first-page":"784","article-title":"Malaria vector control in South Africa","volume":"103","author":"Brook","year":"2013"},{"key":"b19","article-title":"Malaria Vector Surveillance Report, South Africa, January\u2013December 2022.","author":"Dahan-Moss","year":"2024"},{"key":"b20","article-title":"National Malaria Diagnosis Quality Assurance Guidelines: 2011.","year":"2011"},{"key":"b21","series-title":"Parasitol Today","first-page":"303","article-title":"PCR and strain identification in Plasmodium falciparum.","volume":"9","author":"Wooden","year":"1993"},{"key":"b22","series-title":"Ann Trop Med Parasitol","first-page":"131","article-title":"Use of a rapid, signal-round multiplex PCR to detect malarial parasites and identify the species present","volume":"97","author":"Padley","year":"2003"},{"issue":"3","key":"b23","series-title":"PLoS Med","first-page":"e1001788","article-title":"Ultra-sensitive detection of Plasmodium falciparum by amplification of multi-copy subtelomeric targets","volume":"12","author":"Hofmann","year":"2015"},{"key":"b24","series-title":"J Antimicrob Chemother","first-page":"1197","article-title":"Chloroquine-resistant Plasmodium falciparum infections among UK travelers returning with malaria after chloroquine prophylaxis","volume":"59","author":"Sutherland","year":"2007"},{"issue":"4","key":"b25","series-title":"Mol Microbiol","first-page":"913","article-title":"pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum.","volume":"57","author":"Sidhu","year":"2005"},{"key":"b26","series-title":"PLoS One","first-page":"e0136099","article-title":"Genetic analysis and species-specific amplification of the artemisinin resistance-associated kelch propeller domain in P. falciparum and P. vivax.","volume":"10","author":"Talundzic","year":"2015"},{"key":"b27","series-title":"BMC Med","first-page":"1","article-title":"Association of mutations in the Plasmodium falciaparum Kelch13 gene (Pf3D7_1343700) with parasite clearance rates after artemisinin-based treatments \u2013 A WWARN individual patient data meta-analysis","volume":"17","year":"2019"},{"key":"b28","series-title":"Sci Rep","first-page":"10737","article-title":"Sensitive and modular amplicon sequencing of Plasmodium falciparum diversity and resistance for research and public health","volume":"15","author":"Aranda-D\u00edaz","year":"2025"},{"key":"b29","series-title":"Am J Trop Med","first-page":"44","article-title":"High prevalence of molecular markers associated with artemisinin, sulphadoxine and pyrimethamine resistance in Northern Namibia","volume":"115","author":"Eloff","year":"2026"},{"issue":"1","key":"b30","series-title":"Sci Rep","first-page":"13107","article-title":"A multiplex qPCR approach for detection of pfhrp2 and pfhrp3 gene deletions in multiple strain infection of Plasmodium falciparum.","volume":"9","author":"Schindler","year":"2019"},{"key":"b31","series-title":"EBioMedicine","first-page":"102757","article-title":"A novel multiplex qPCR assay for detection of Plasmodium falciparum with histidine-rich protein 2 and 3 (pfhrp2 and pfhrp3) deletions in polyclonal infections","volume":"55","author":"Grignard","year":"2020"},{"key":"b32","article-title":"Artemisinin Resistance and Artemisinin-Based Combination Therapy Efficacy: Status Report.","year":"2018"},{"issue":"3","key":"b33","series-title":"J Infect Dis","first-page":"380","article-title":"Molecular markers for failure of sulfadoxine-pyrimethamine and chloroproguanil-dapsone treatment of Plasmodium falciparum malaria","volume":"185","author":"Kublin","year":"2002"},{"issue":"9","key":"b34","series-title":"Antimicrob Agents Chemother","first-page":"3793","article-title":"In vitro activity of antifolate and polymorphism in dihydrofolate reductase of Plasmodium falciparum isolates from the Kenyan coast: Emergence of parasites with Ile-164-Leu mutation","volume":"53","author":"Kiara","year":"2009"},{"issue":"8","key":"b35","series-title":"Trop Med Int Health","first-page":"605","article-title":"Polymorphisms in the dihydrofolate reductase (DHFR) and dihydropteroate synthetase (DHPS) genes of Plasmodium falciparum and in\u00a0vivo resistance to sulphadoxine\/pyrimethamine in isolates from Tanzania","volume":"3","author":"Jelinek","year":"1998"},{"issue":"9364","key":"b36","series-title":"Lancet","first-page":"1174","article-title":"Antifolate antimalarial resistance in southeast Africa: A population-based analysis","volume":"361","author":"Roper","year":"2003"},{"issue":"4","key":"b37","series-title":"N Engl J Med","first-page":"257","article-title":"A molecular marker for chloroquine-resistant falciparum malaria","volume":"344","author":"Djimd\u00e9","year":"2001"},{"issue":"5","key":"b38","series-title":"J Infect Dis","first-page":"750","article-title":"In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa","volume":"199","author":"Sisowath","year":"2009"},{"issue":"4","key":"b39","series-title":"Am J Trop Med Hyg","first-page":"833","article-title":"Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: Parasite risk factors that affect treatment outcomes for P. Falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine","volume":"91","author":"Venkatesan","year":"2014"},{"issue":"1","key":"b40","series-title":"S Afr Med J","first-page":"13","article-title":"Maintaining focus on administering effective malaria treatment during the COVID-19 pandemic","volume":"111","author":"Raman","year":"2020"},{"issue":"1","key":"b41","series-title":"Malar J","first-page":"209","article-title":"Safety and tolerability of single low-dose primaquine in a low intensity transmission area in South Africa: An open-label randomized controlled trial","volume":"18","author":"Raman","year":"2019"},{"issue":"12","key":"b42","series-title":"Commun Dis Commun","first-page":"12","article-title":"Malaria treatment: First detection of the Plasmodium falciparum kelch13 Q613E mutation in South Africa","volume":"20","year":"2021"},{"issue":"3","key":"b43","series-title":"Commun Dis Commun","first-page":"3","article-title":"Malaria update: Increase in frequency of kelch13 mutations found in malaria parasites from Mpumalanga Province, an early warning of the possible emergence of artemisinin-resistant malaria","volume":"21","year":"2022"},{"key":"b44","series-title":"Am J Trop Med","first-page":"65","article-title":"Plasmodium falciparum genomic surveillance reveals a diversity of Kelch 13 mutations in Zambia","volume":"115","author":"Aranda-Diaz","year":"2026"},{"key":"b45","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiaf188","article-title":"Emergence and Rising Prevalence of Artemisinin Partial Resistance Marker Kelch13 P441L in a Low Transmission Setting in Southern Zambia.","author":"Martin","year":"2025"},{"issue":"7","key":"b46","series-title":"Nat Med","first-page":"1807","article-title":"Urgent action is needed to confront artemisinin partial resistance in African parasites","volume":"30","author":"Ishengoma","year":"2024"},{"issue":"5","key":"b47","series-title":"PLoS One","first-page":"e64299","article-title":"The role of Pfmdr1 and Pfcrt in changing chloroquine, amodiaquine, mefloquine and lumefantrine susceptibility in western-Kenya P. falciparum samples during 2008\u20132011","volume":"8","author":"Eyase","year":"2013"},{"issue":"4","key":"b48","series-title":"BMJ Glob Health","first-page":"e000999","article-title":"Emerging implications of policies on malaria treatment: Genetic changes in the Pfmdr-1 gene affecting the susceptibility to artemether-lumefantrine and artesunate-amodiaquine in Africa","volume":"3","author":"Okell","year":"2018"},{"issue":"9","key":"b49","series-title":"Lancet Microbe","first-page":"e441","article-title":"Drug susceptibility of Plasmodium falciparum in eastern Uganda: A longitudinal phenotypic and genotypic study","volume":"2","author":"Tumwebaze","year":"2021"},{"issue":"1","key":"b50","series-title":"Nature Commun","first-page":"6353","article-title":"Decreased susceptibility of Plasmodium falciparum to both dihydroartemisinin and lumefantrine in northern Uganda","volume":"13","author":"Tumwebaze","year":"2022"},{"issue":"5","key":"b51","series-title":"Antimicrob Agents Chemother","first-page":"e01949-20","article-title":"Continued low efficacy of artemether-lumefantrine in Angola in 2019","volume":"65","author":"Dimbu","year":"2021"},{"issue":"4","key":"b52","series-title":"Am J Trop Med Hyg","first-page":"1067","article-title":"Therapeutic efficacy of artemisinin-based combination therapies in Democratic Republic of the Congo and investigation of molecular markers of antimalarial resistance","volume":"105","author":"Moriarty","year":"2021"},{"issue":"7","key":"b53","series-title":"J Infect Dis","first-page":"1110","article-title":"Return of widespread chloroquine-sensitive Plasmodium falciparum to Malawi","volume":"210","author":"Frosch","year":"2014"},{"issue":"1","key":"b54","series-title":"Parasite Vectors","first-page":"355","article-title":"Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China","volume":"10","author":"Lu","year":"2017"},{"issue":"10 Pt 2","key":"b55","series-title":"S Afr Med J","first-page":"793","article-title":"Case management of malaria: Treatment and chemoprophylaxis","volume":"103","author":"Upke","year":"2013"},{"issue":"8","key":"b56","series-title":"J Clin Invest","first-page":"1084","article-title":"Antimalarial drug resistance","volume":"113","author":"White","year":"2004"},{"issue":"1","key":"b57","series-title":"Malar J","first-page":"74","article-title":"An exploratory study of factors that affect the performance and usage of rapid diagnostic tests for malaria in the Limpopo Province, South Africa","volume":"6","author":"Moonasar","year":"2007"},{"issue":"1","key":"b58","series-title":"Malar J","first-page":"402","article-title":"Molecular surveillance of Plasmodium falciparum histidine-rich protein 2\/3 gene deletions in Mozambique, 2023","volume":"23","author":"da Silva","year":"2024"},{"issue":"1","key":"b59","series-title":"Sci Rep","first-page":"16024","article-title":"Molecular detection of sub-microscopic infections and Plasmodium falciparum histidine-rich protein-2 and 3 gene deletions in pre-elimination settings of South Africa","volume":"14","author":"Oyegoke","year":"2024"},{"issue":"8","key":"b60","series-title":"J Infect Dis","first-page":"1346","article-title":"High genetic diversity of Plasmodium falciparum in the low-transmission setting of the Kingdom of Eswatini","volume":"220","author":"Roh","year":"2019"},{"issue":"8","key":"b61","series-title":"Parasitol Today","first-page":"241","article-title":"Spread of chloroquine resistance in Plasmodium falciparum.","volume":"3","author":"Payne","year":"1987"},{"issue":"10","key":"b62","series-title":"PLoS Comput Biol","first-page":"e1010317","article-title":"Spatiotemporal spread of Plasmodium falciparum mutation for resistance to sulfadoxine-pyrimethamine across Africa, 1999\u20132020","volume":"18","author":"Flegg","year":"2022"},{"key":"b63","article-title":"World Malaria Report.","year":"2024"},{"issue":"1","key":"b64","series-title":"Malar J","first-page":"152","article-title":"High levels of imported asymptomatic malaria but limited local transmission in KwaZulu-Natal, a South Africa malaria-endemic province nearing malaria elimination","volume":"19","author":"Raman","year":"2020"},{"issue":"8","key":"b65","series-title":"S Afr Med J","first-page":"e1736","article-title":"The prevalence and distribution of malaria in Mpumalanga Province before and during COVID-19 (2017-2022)","volume":"114","author":"Kleinhans","year":"2024"},{"issue":"1","key":"b66","series-title":"Malar J","first-page":"70","article-title":"Malaria risk in young male travellers but local transmission persists: A case-control study in low transmission Namibia","volume":"16","author":"Smith","year":"2017"},{"issue":"4","key":"b67","series-title":"PLoS One","first-page":"e95341","article-title":"Men travelling away from home are more likely to bring malaria into high altitude villages, Northwest Ethiopia","volume":"9","author":"Alemu","year":"2014"},{"key":"b68","article-title":"A Review of Malaria Trends in South Africa for the 2022\u20132023 Malaria Season Based on the Notifiable Medical Condition Surveillance System.","author":"Mabona","year":"2024"}],"container-title":["The American Journal of Tropical Medicine and Hygiene"],"original-title":[],"link":[{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/115\/5_Suppl\/article-p53.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/115\/5_Suppl\/article-p53.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/115\/5_Suppl\/article-p53.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T16:04:54Z","timestamp":1793808294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/115\/5_Suppl\/article-p53.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11,3]]},"references-count":68,"journal-issue":{"issue":"5_Suppl"},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.25-0204","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,11,3]]}}}